Cargando…

Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study

BACKGROUND: Enhanced cardiovascular secondary preventive follow-up is needed to improve adherence to recommended low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP) levels. Patients with diabetes mellitus (DM) or chronic kidney disease (CKD) have a high risk of recurrent events. Seco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakobsson, Stina, Irewall, Anna-Lotta, Bjorklund, Fredrik, Mooe, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607173/ https://www.ncbi.nlm.nih.gov/pubmed/26466804 http://dx.doi.org/10.1186/s12872-015-0115-0

Ejemplares similares

Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial
por: Jakobsson, Stina, et al.
Publicado: (2016)

Nurse-based secondary preventive follow-up by telephone reduced recurrence of cardiovascular events: a randomised controlled trial
por: Irewall, Anna-Lotta, et al.
Publicado: (2021)

Nurse-led, telephone-based secondary preventive follow-up benefits stroke/TIA patients with low education: a randomized controlled trial sub-study
por: Irewall, Anna-Lotta, et al.
Publicado: (2019)

The NAILED stroke risk factor trial (Nurse based Age independent Intervention to Limit Evolution of Disease after stroke): study protocol for a randomized controlled trial
por: Mooe, Thomas, et al.
Publicado: (2013)

Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial
por: Ögren, Joachim, et al.
Publicado: (2018)

Nurse-Led, Telephone-Based, Secondary Preventive Follow-Up after Stroke or Transient Ischemic Attack Improves Blood Pressure and LDL Cholesterol: Results from the First 12 Months of the Randomized, Controlled NAILED Stroke Risk Factor Trial
por: Irewall, Anna-Lotta, et al.
Publicado: (2015)

The Nurse-Based Age Independent Intervention to Limit Evolution of Disease After Acute Coronary Syndrome (NAILED ACS) Risk Factor Trial: Protocol for a Randomized Controlled Trial
por: Mooe, Thomas, et al.
Publicado: (2014)

Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial
por: Huber, Daniel, et al.
Publicado: (2017)

Long-term risk of major adverse cardiovascular events following ischemic stroke or TIA
por: Carlsson, Andreas, et al.
Publicado: (2023)

Implementation of Telephone-Based Secondary Preventive Intervention after Stroke and Transient Ischemic Attack – Participation Rate, Reasons for Nonparticipation and One-Year Mortality
por: Irewall, Anna-Lotta, et al.
Publicado: (2014)

Incidence and predictors of cardiovascular outcomes after acute coronary syndrome in a population-based cohort study
por: Ulvenstam, Anders, et al.
Publicado: (2023)

Serious hemorrhages after ischemic stroke or TIA – Incidence, mortality, and predictors
por: Ögren, Joachim, et al.
Publicado: (2018)

Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): participation rate, reasons for non-participation and 1-year survival
por: Huber, Daniel, et al.
Publicado: (2016)

The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction
por: Henriksson, Robin, et al.
Publicado: (2019)

The impact of platelet function or C-reactive protein, on cardiovascular events after an acute myocardial infarction
por: Modica, Angelo, et al.
Publicado: (2009)

Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population
por: Nilsson, Gunnar, et al.
Publicado: (2016)

Nurse-led, telephone-based follow-up after acute coronary syndrome yields improved risk factors after 36 months: the randomized controlled NAILED-ACS trial
por: Henriksson, Robin, et al.
Publicado: (2021)

Incidence and predictors of serious bleeding during long-term follow-up after acute coronary syndrome in a population-based cohort study
por: Graipe, Anna, et al.
Publicado: (2021)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials
por: Zhu, Houyong, et al.
Publicado: (2023)

Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study—Secondary Analysis of the Randomized Trial
por: Uusitupa, Matti, et al.
Publicado: (2009)

Statin treatment after acute coronary syndrome: Adherence and reasons for non-adherence in a randomized controlled intervention trial
por: Daniel, Huber, et al.
Publicado: (2019)

Feasibility of Bariatric Surgery as a Strategy for Secondary Prevention in Cardiovascular Disease: A Report from the Swedish Obese Subjects Trial
por: Delling, Lotta, et al.
Publicado: (2010)

Risk factors in cardiovascular patients: Challenges and opportunities to improve secondary prevention
por: Gabulova, Rahima, et al.
Publicado: (2023)

Implementation of the Swedish Guideline for Prevention of Mental ill-health at the Workplace: study protocol of a cluster randomized controlled trial, using multifaceted implementation strategies in schools
por: Kwak, Lydia, et al.
Publicado: (2019)

Targeted proteomics improves cardiovascular risk prediction in secondary prevention
por: Nurmohamed, Nick S., et al.
Publicado: (2022)

Diabetes: how to manage cardiovascular risk in secondary prevention patients
por: Anderson, Sarah L, et al.
Publicado: (2022)

Different inflammatory pathways underlying cardiovascular risk in secondary prevention( )
por: Nurmohamed, Nick S, et al.
Publicado: (2022)

Author Correction: Statin treatment after acute coronary syndrome: Adherence and reasons for non-adherence in a randomized controlled intervention trial
por: Huber, Daniel, et al.
Publicado: (2021)

Effect of the Polypill on Adherence and Prevention of Cardiovascular Diseases in Patients With or at High Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials
por: Memon, Rahat A, et al.
Publicado: (2023)

Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ye, Yuyang, et al.
Publicado: (2023)

P2Y(12) inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials
por: Aggarwal, Devika, et al.
Publicado: (2022)

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
por: Fragoulakis, Vassilis, et al.
Publicado: (2012)

Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
por: van Schaik, T. M., et al.
Publicado: (2017)

Diet and Exercise Interventions among Overweight and Obese Lactating Women: Randomized Trial of Effects on Cardiovascular Risk Factors
por: Brekke, Hilde K., et al.
Publicado: (2014)

Effects of dietary and exercise treatments on HDL subclasses in lactating women with overweight and obesity: a secondary analysis of a randomised controlled trial
por: Øhman, Elisabeth Adolfsen, et al.
Publicado: (2022)

Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial
por: Hegde, Sheila M., et al.
Publicado: (2023)

Affect-focused psychodynamic psychotherapy for depression and anxiety through the Internet: a randomized controlled trial
por: Johansson, Robert, et al.
Publicado: (2013)

Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention
por: Gynnild, Mari Nordbø, et al.
Publicado: (2021)

Selenium and Coenzyme Q(10) Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality—Sub-Study of a Randomized Clinical Trial
por: Opstad, Trine Baur, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_63qil0cevi2freqa5oans1frlg